Patents by Inventor Yinjue Wang

Yinjue Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OXM3 STORAGE AGENT, OXM3 FORMULATION AND PREPARATION METHOD
    Publication number: 20240197833
    Abstract: Disclosed are an OXM3 storage agent, an OXM3 formulation and a preparation method. The OXM3 storage agent comprises 0.5-5 mg/mL tromethamine, 0.1-100 mg/mL stabilizer, 0.01-5 mg/mL chelating agent and a solvent, wherein: the stabilizer comprises one or more of mannitol, propylene glycol, arginine, arginine hydrochloride, histidine and histidine hydrochloride, the chelating agent comprises edetate disodium, and the solvent comprises water. The OXM3 formulation prepared from the OXM3 storage agent can ensure that the active ingredient OXM3 is stably stored for at least 6 months, preferably for 12 months or more, and more preferably for 18-24 months or more.
    Type: Application
    Filed: April 28, 2022
    Publication date: June 20, 2024
    Applicant: INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
    Inventors: Chengcheng ZHAO, Yinjue WANG, Jingda WANG
  • PD-L1/LAG-3 BISPECIFIC ANTIBODY FORMULATION AND PREPARATION METHOD THEREFOR AND USE THEREOF
    Publication number: 20230287124
    Abstract: The present invention relates to a formulation comprising a PD-L1/LAG-3 bispecific antibody, and particularly to a pharmaceutical formulation comprising a PD-L1/LAG-3 bispecific antibody, a buffer, a stabilizer, a surfactant and a chelating agent. Furthermore, the present invention further relates to therapeutic or prophylactic use of these formulations.
    Type: Application
    Filed: July 22, 2021
    Publication date: September 14, 2023
    Inventors: Tianyi YAO, Yidong MA, Yinjue WANG
  • FORMULATION COMPRISING ANTI-IL-23P19 ANTIBODY, METHOD FOR PREPARING SAME AND USE THEREOF
    Publication number: 20230173069
    Abstract: The present invention relates to a formulation comprising an anti-IL-23p19 antibody, and in particular to a pharmaceutical formulation comprising an anti-IL-23p19 antibody, a buffer, a stabilizer and a surfactant. Furthermore, the present invention further relates to therapeutic or prophylactic use of these formulations.
    Type: Application
    Filed: May 12, 2021
    Publication date: June 8, 2023
    Inventors: Wei CAO, Liqiang MA, Yinjue WANG, Kaisong ZHOU
  • RECOMBINANT FULLY HUMAN ANTI-TIGIT MONOCLONAL ANTIBODY FORMULATION, METHOD FOR PREPARING SAME AND USE THEREOF
    Publication number: 20230080706
    Abstract: The present invention relates to formulations comprising an anti-TIGIT antibody, and in particular to a pharmaceutical formulation comprising an anti-TIGIT antibody, a buffer, a stabilizer and a surfactant. Furthermore, the present invention further relates to therapeutic or prophylactic use of these formulations.
    Type: Application
    Filed: January 19, 2021
    Publication date: March 16, 2023
    Inventors: Haitao ZHANG, Liqiang MA, Yinjue WANG
  • FORMULATION COMPRISING ANTI-PD-1/HER2 BISPECIFIC ANTIBODY, METHOD FOR PREPARING SAME AND USE THEREOF
    Publication number: 20220281972
    Abstract: The present invention relates to formulations comprising an anti-PD-1/HER2 bispecific antibody, and in particular to a pharmaceutical formulation comprising the anti-PD-1/HER2 bispecific antibody, a buffer, a stabilizer and a surfactant. Furthermore, the present invention also relates to therapeutic or prophylactic use of these formulations.
    Type: Application
    Filed: August 6, 2020
    Publication date: September 8, 2022
    Inventors: Yanghan LIU, Yidong MA, Yinjue WANG, Kaisong ZHOU
  • FORMULATION COMPRISING ANTI-CD47/PD-L1 BISPECIFIC ANTIBODY, METHOD FOR PREPARING SAME AND USE THEREOF
    Publication number: 20220251210
    Abstract: The present invention relates to formulations comprising an anti-CD47/PD-L1 bispecific antibody, and in particular to pharmaceutical formulations comprising an anti-CD47/PD-L1 bispecific antibody, a buffer, a stabilizer and a surfactant. Furthermore, the present invention also relates to therapeutic or prophylactic use of these formulations.
    Type: Application
    Filed: June 24, 2020
    Publication date: August 11, 2022
    Inventors: Xinggui ZHU, Yidong MA, Yinjue WANG, Kaisong ZHOU
  • FORMULATION COMPRISING ANTI-LAG-3 ANTIBODY, METHOD FOR PREPARING SAME AND USE THEREOF
    Publication number: 20220251188
    Abstract: The present invention relates to formulations comprising an anti-LAG-3 antibody, and in particular to pharmaceutical formulations comprising an antibody specifically binding to LAG-3 molecules, a buffer, a stabilizer and a surfactant. Furthermore, the present invention also relates to therapeutic or prophylactic use of these formulations.
    Type: Application
    Filed: June 24, 2020
    Publication date: August 11, 2022
    Inventors: Tianyi YAO, Yidong MA, Yinjue WANG, Kaisong ZHOU
  • FORMULATION COMPRISING ANTI-CD47 ANTIBODY, PREPARATION METHOD THEREFOR AND USE THEREOF
    Publication number: 20220143180
    Abstract: The present invention relates to a formulation comprising an anti-CD47 antibody, and in particular to a pharmaceutical formulation comprising an antibody, a buffer, a stabilizer and a surfactant. Furthermore, the present invention also relates to therapeutic or prophylactic use of those formulations.
    Type: Application
    Filed: February 25, 2020
    Publication date: May 12, 2022
    Inventors: Ruixia XIE, Liqiang MA, Yinjue WANG, Kaisong ZHOU
  • PREPARATION COMPRISING ANTI-PCSK9 ANTIBODY AND USE THEREOF
    Publication number: 20220062416
    Abstract: The present invention relates to a preparation comprising an anti-PCSK9 antibody and use thereof, and in particular to a pharmaceutical preparation comprising an antibody and/or an antibody fragment specifically binding to proprotein convertase subtilisin/kexin type 9 (PCSK9), a buffer, a viscosity inhibitor, and a surfactant. The present invention also relates to an anti-PCSK9 antibody. Furthermore, the present invention relates to therapeutic and diagnostic use of the preparation or the antibody.
    Type: Application
    Filed: May 10, 2019
    Publication date: March 3, 2022
    Inventors: Yinjue WANG, Xiaolin LIU, Ruixia XIE
  • Stable liquid formulations of recombinant fusion proteins
    Patent number: 10293045
    Abstract: Provided is a liquid formulation that enables the stable storage of recombinant fusion proteins, comprising a recombinant fusion protein, a buffer salt, a stabilizer, and a surfactant.
    Type: Grant
    Filed: September 25, 2015
    Date of Patent: May 21, 2019
    Assignee: INNOVENT BIOLOGICS, INC.
    Inventors: Yinjue Wang, Junfeng Li, Xiaole Huang
  • RECOMBINANT FUSION PROTEIN FORMULATION
    Publication number: 20190038746
    Abstract: Provided is a liquid formulation that enables the stable storage of recombinant fusion proteins, comprising a recombinant fusion protein, a buffer salt, a stabilizer, and a surfactant.
    Type: Application
    Filed: September 25, 2015
    Publication date: February 7, 2019
    Applicant: INNOVENT BIOLOGICS, INC.
    Inventors: Yinjue Wang, Junfeng Li, Xiaole Huang
  • Stable liquid formulations of recombinant fusion proteins
    Patent number: 10071136
    Abstract: Provided is a liquid formulation that enables the stable storage of recombinant fusion proteins, comprising a recombinant fusion protein, a buffer salt, a stabilizer, and a surfactant.
    Type: Grant
    Filed: September 25, 2015
    Date of Patent: September 11, 2018
    Assignee: INNOVENT BIOLOGICS, INC.
    Inventors: Yinjue Wang, Junfeng Li, Xiaole Huang
  • RECOMBINANT FUSION PROTEIN FORMULATION
    Publication number: 20180147258
    Abstract: Provided is a liquid formulation that enables the stable storage of recombinant fusion proteins, comprising a recombinant fusion protein, a buffer salt, a stabilizer, and a surfactant.
    Type: Application
    Filed: September 25, 2015
    Publication date: May 31, 2018
    Inventors: Yinjue Wang, Junfeng Li, Xiaole Huang